Oliver Seifert

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Epidermal Growth Factor Receptor

Tyrosine Kinase

Top Venues

Molecules (Basel, Switzerland)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Leila Abassi, Federico Bertoglio, Željka Mačak Šafranko, Thomas Schirrmann, Marina Greweling-Pils, Oliver Seifert, Fawad Khan, Maeva Katzmarzyk, Henning Jacobsen, Natascha Gödecke, Philip Alexander Heine, André Frenzel, Helena Nowack, Stefan Dübel, Ivan-Christian Kurolt, Roland E Kontermann, Alemka Markotić, Maren Schubert, Michael Hust, Luka Čičin Šain
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns. Viruses 15 (11) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Lennart Kühl, Nadine Beha, Roland E Kontermann, Oliver Seifert
The eIg technology to generate Ig-like bispecific antibodies. mAbs 14 (1) (2022)
Nadine Beha, Katharina Kocher, Martin Siegemund, Martina S Lutz, Lennart Kühl, Oliver Seifert, Roland E Kontermann
Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). Oncoimmunology 11 (1) (2022)
Oliver Seifert, Roland E Kontermann
GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments. Molecules (Basel, Switzerland) 27 (10) (2022)
Alexander Rau, Katharina Kocher, Mirjam Rommel, Lennart Kühl, Maximilian Albrecht, Hannes Gotthard, Nadine Beha, Bettina Noll, Monilola A Olayioye, Roland E Kontermann, Oliver Seifert
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3. mAbs 13 (1) (2022)
Nivetha Krishna Moorthy, Oliver Seifert, Stephan Eisler, Sara Weirich, Roland E Kontermann, Markus Rehm, Gavin Fullstone
Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma. Molecules (Basel, Switzerland) 26 (24) (2021)
Alexander Rau, Wolfgang S Lieb, Oliver Seifert, Jonas Honer, Dennis Birnstock, Fabian Richter, Nadine Aschmoneit, Monilola A Olayioye, Roland E Kontermann
Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3. Molecular cancer therapeutics 19 (7) (2020)
Myriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A Eisler, Roland E Kontermann, Klaus Pfizenmaier, So Young Lee, María dM Vivanco, Pedro P López-Casas, Sofia Perea, Muhammad Abbas, Wolfgang Richter, Laureano Simon, Manuel Hidalgo
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Oliver Seifert, Alexander Rau, Nadine Beha, Fabian Richter, Roland E Kontermann
Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules. mAbs 11 (5) (2019)
Fabian Richter, Oliver Seifert, Andreas Herrmann, Klaus Pfizenmaier, Roland E Kontermann
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc. mAbs 11 (4) (2019)
Fabian Richter, Kirstin A Zettlitz, Oliver Seifert, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, Roland E Kontermann
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity. mAbs 11 (1) (2018)
Lisa C Schmitt, Alexander Rau, Oliver Seifert, Jonas Honer, Meike Hutt, Simone Schmid, Jonas Zantow, Michael Hust, Stefan Dübel, Monilola A Olayioye, Roland E Kontermann
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV. mAbs 9 (5) (2017)